Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Ho

Showing results (61-70 of 74) with videos related to

Pageof 8
Sort By:
Cancers|August 26, 2022
Treatment Outcomes of Computer Tomography-Guided Brachytherapy in Cervical Cancer in Hong Kong: A Retrospective ReviewWing-Lok Chan, Matthew Ho-Fai Cheng, Jacky Tsun-Kit Wu, et al.
American Journal of Hematology|July 8, 2023
Natural history, predictors of development of extramedullary disease, and treatment outcomes for patients with extramedullary multiple myelomaSaurabh Zanwar, Matthew Ho, Yi Lin, et al.
Blood|March 19, 2020
YWHAE/14-3-3ε expression impacts the protein load, contributing to proteasome inhibitor sensitivity in multiple myelomaYan Xu, Mariateresa Fulciniti, Mehmet K Samur, et al.
European Journal of Cancer (Oxford, England : 1990)|February 14, 2023
Risk of residual cancer after complete response following first-line chemotherapy in men with metastatic non-seminomatous germ cell tumour and International Germ Cell Cancer Cooperative Group intermediate/poor prognosis: A multi-institutional retrospective cohort studyLuca Antonelli, Davide Ardizzone, Praful Ravi, et al.
European Urology Focus|November 17, 2024
Oncological Outcomes Following Robotic Postchemotherapy Retroperitoneal Lymph Node Dissection for Testicular Cancer: A Worldwide Multicenter StudyAlireza Ghoreifi, Farshad Sheybaee Moghaddam, Anirban P Mitra, et al.
Urologic Oncology|August 8, 2025
Bacillus Calmette-Guérin (BCG) in combination with PANVAC™ vs. BCG alone in adults with high-grade BCG-refractory non-muscle-invasive bladder cancerMatthew Ho, Alon Lazarovich, Ragheed Saoud, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 2023
Risk Factors for Relapse in Nonseminomatous Testicular Cancer After Postchemotherapy Retroperitoneal Lymph Node Dissection With Viable Residual CancerLuca Antonelli, Davide Ardizzone, Isamu Tachibana, et al.
BJU International|December 11, 2024
Primary retroperitoneal lymph node dissection in clinical stage 2a/b non-seminomatous germ cell tumourLuca Antonelli, Axel Heidenreich, Aditya Bagrodia, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 5, 2021
CAG RNAs induce DNA damage and apoptosis by silencing <i>NUDT16</i> expression in polyglutamine degenerationShaohong Peng, Pei Guo, Xiao Lin, et al.
Blood Cancer Journal|November 24, 2022
Second symptomatic COVID-19 infections in patients with an underlying monoclonal gammopathySaurabh Zanwar, Matthew Ho, Francis K Buadi, et al.
Pageof 8

Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
Cancers|August 26, 2022
Treatment Outcomes of Computer Tomography-Guided Brachytherapy in Cervical Cancer in Hong Kong: A Retrospective ReviewWing-Lok Chan, Matthew Ho-Fai Cheng, Jacky Tsun-Kit Wu, et al.
American Journal of Hematology|July 8, 2023
Natural history, predictors of development of extramedullary disease, and treatment outcomes for patients with extramedullary multiple myelomaSaurabh Zanwar, Matthew Ho, Yi Lin, et al.
Blood|March 19, 2020
YWHAE/14-3-3ε expression impacts the protein load, contributing to proteasome inhibitor sensitivity in multiple myelomaYan Xu, Mariateresa Fulciniti, Mehmet K Samur, et al.
European Journal of Cancer (Oxford, England : 1990)|February 14, 2023
Risk of residual cancer after complete response following first-line chemotherapy in men with metastatic non-seminomatous germ cell tumour and International Germ Cell Cancer Cooperative Group intermediate/poor prognosis: A multi-institutional retrospective cohort studyLuca Antonelli, Davide Ardizzone, Praful Ravi, et al.
European Urology Focus|November 17, 2024
Oncological Outcomes Following Robotic Postchemotherapy Retroperitoneal Lymph Node Dissection for Testicular Cancer: A Worldwide Multicenter StudyAlireza Ghoreifi, Farshad Sheybaee Moghaddam, Anirban P Mitra, et al.
Urologic Oncology|August 8, 2025
Bacillus Calmette-Guérin (BCG) in combination with PANVAC™ vs. BCG alone in adults with high-grade BCG-refractory non-muscle-invasive bladder cancerMatthew Ho, Alon Lazarovich, Ragheed Saoud, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 2023
Risk Factors for Relapse in Nonseminomatous Testicular Cancer After Postchemotherapy Retroperitoneal Lymph Node Dissection With Viable Residual CancerLuca Antonelli, Davide Ardizzone, Isamu Tachibana, et al.
BJU International|December 11, 2024
Primary retroperitoneal lymph node dissection in clinical stage 2a/b non-seminomatous germ cell tumourLuca Antonelli, Axel Heidenreich, Aditya Bagrodia, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 5, 2021
CAG RNAs induce DNA damage and apoptosis by silencing <i>NUDT16</i> expression in polyglutamine degenerationShaohong Peng, Pei Guo, Xiao Lin, et al.
Blood Cancer Journal|November 24, 2022
Second symptomatic COVID-19 infections in patients with an underlying monoclonal gammopathySaurabh Zanwar, Matthew Ho, Francis K Buadi, et al.
Pageof 8